{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:39:46Z","timestamp":1780346386870,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ygyno.2019.09.017","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:24:29Z","timestamp":1574295869000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data"],"prefix":"10.1016","volume":"156","author":[{"given":"Parth A.","family":"Chodavadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corbin D.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Havrilesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo P.","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.09.017_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"Cancer Journal for Clinicians"},{"key":"10.1016\/j.ygyno.2019.09.017_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in Oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J.\u00a0Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2019.09.017_bib3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial","volume":"355","author":"Creutzberg","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.ygyno.2019.09.017_bib4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2019.09.017_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ygyno.2019.09.017_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A\u00a0phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.017_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2013.08.014","article-title":"Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer","volume":"87","author":"Nagar","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2019.09.017_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2018.12.010","article-title":"Evolving trends in the management of high-intermediate risk endometrial cancer in the United States","volume":"152","author":"Zakem","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2019.09.017_bib9","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.017_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.017_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2017.09.008","article-title":"A\u00a0phase 3 trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy in patients with high-risk, early-stage endometrial cancer: a Gynecology Oncology group study","volume":"99","author":"Randall","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2019.09.017_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.017_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jso.23568","article-title":"Comparing national cancer registries: the national cancer data base (NCDB) and the surveillance, epidemiology, and end results (SEER) program","volume":"109","author":"Mohanty","year":"2014","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.ygyno.2019.09.017_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00118","article-title":"Radiation records in the national cancer database: variations in coding and\/or practice can significantly alter survival results","volume":"3","author":"Jacobs","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.ygyno.2019.09.017_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2019.09.017_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.6004\/jnccn.2009.0035","article-title":"Uterine neoplasms. Clinical practice guidelines in Oncology","volume":"7","author":"Greer","year":"2009","journal-title":"J.\u00a0Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2019.09.017_bib17","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1001\/jama.284.22.2886","article-title":"Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy","volume":"284","author":"Gross","year":"2000","journal-title":"Jama"},{"issue":"46","key":"10.1016\/j.ygyno.2019.09.017_bib18","first-page":"2422","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2013results from two randomised studies. European journal of cancer","volume":"1990","author":"Hogberg","year":"2010","journal-title":"Oxford, England"},{"key":"10.1016\/j.ygyno.2019.09.017_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bmj.329.7463.425","article-title":"National questionnaire survey on what influences doctors\u2019 decisions about admission to intensive care","volume":"329","author":"Escher","year":"2004","journal-title":"Bmj"},{"key":"10.1016\/j.ygyno.2019.09.017_bib20","first-page":"117","article-title":"Decision making and quality of life in the treatment of cancer: a review","volume":"17","author":"Zafar","year":"2009","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ygyno.2019.09.017_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/CMAR.S119125","article-title":"Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?","volume":"9","author":"Sabater","year":"2017","journal-title":"Cancer Manag. Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819315380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:48:18Z","timestamp":1758772098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819315380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0090825819315380"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.017","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-study utilization of experimental therapies: Analysis of GOG249-eligible cohorts using real world data","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}